HEALTH● LOWJul 16 · Jul 16, 2026, 10:48 AM
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction
CNBC
The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and MDMA.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTHnowKenya: 20 Ebola contacts released from quarantineUN NewsHEALTH24m agoYobe Govt Vaccinates 43,720 Children Against PoliomyelitisChannels TVHEALTH46m agoEbola: ₦100,000 weekly allowance for quarantined contacts was unplanned – NCDCPremium TimesHEALTH1h ago64 Students Hospitalised After Reacting To Bilharzia Treatment Drugs In KatsinaChannels TV